Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of multiple dose regimens of RO4402257 in rheumatoid arthritis patients on methotrexate
2005-003495-38Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pamapimod in rheumatoid arthritis (RA) (6 arms), sponsored by Roche. Primary endpoint: ACR20 response at Week 12. Started Sep 2005; status: completed.
02
Drugs
pamapimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-003495-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003495-38.